Follow
M. Reza Skandari, PhD
M. Reza Skandari, PhD
Assistant Professor, Imperial College Business School
Verified email at imperial.ac.uk - Homepage
Title
Cited by
Cited by
Year
Revisiting the time needed to provide adult primary care
J Porter, C Boyd, MR Skandari, N Laiteerapong
Journal of general internal medicine 38 (1), 147-155, 2023
1282023
Total flow time minimization in a flowshop sequence-dependent group scheduling problem
N Salmasi, R Logendran, MR Skandari
Computers & Operations Research 37 (1), 199-212, 2010
1212010
Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial
W Wan, MR Skandari, A Minc, AG Nathan, A Winn, P Zarei, M O’Grady, ...
Diabetes care 41 (6), 1227-1234, 2018
982018
Timing of arteriovenous fistula creation in patients with CKD: a decision analysis
SM Shechter, MR Skandari, N Zalunardo
American journal of kidney diseases 63 (1), 95-103, 2014
712014
Makespan minimization of a flowshop sequence-dependent group scheduling problem
N Salmasi, R Logendran, MR Skandari
The International Journal of Advanced Manufacturing Technology 56, 699-710, 2011
542011
An integrated ant colony optimization approach to compare strategies of clearing market in electricity markets: Agent-based simulation
A Azadeh, MR Skandari, B Maleki-Shoja
Energy Policy 38 (10), 6307-6319, 2010
442010
First-line therapy for type 2 diabetes with sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study
JG Choi, AN Winn, MR Skandari, MI Franco, EM Staab, J Alexander, ...
Annals of internal medicine 175 (10), 1392-1400, 2022
402022
Individualized glycemic control for US adults with type 2 diabetes: a cost-effectiveness analysis
N Laiteerapong, JM Cooper, MR Skandari, PM Clarke, AN Winn, ...
Annals of internal medicine 168 (3), 170-178, 2018
382018
The impact of biomarker screening and cascade genetic testing on the cost-effectiveness of MODY genetic testing
MS GoodSmith, MR Skandari, ES Huang, RN Naylor
Diabetes Care 42 (12), 2247-2255, 2019
342019
Cost-effectiveness of shared telemedicine appointments in young adults with T1D: CoYoT1 trial
W Wan, AG Nathan, MR Skandari, P Zarei, MW Reid, JK Raymond, ...
Diabetes Care 42 (8), 1589-1592, 2019
202019
Cost-effectiveness of initiating an insulin pump in T1D adults using continuous glucose monitoring compared with multiple daily insulin injections: the DIAMOND randomized trial
W Wan, MR Skandari, A Minc, AG Nathan, P Zarei, AN Winn, M O’Grady, ...
Medical Decision Making 38 (8), 942-953, 2018
192018
The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis
JT Alexander, EM Staab, W Wan, M Franco, A Knitter, MR Skandari, ...
Journal of general internal medicine, 1-24, 2022
172022
Patient-type Bayes-adaptive treatment plans
MR Skandari, SM Shechter
Operations research 69 (2), 574-598, 2021
162021
Optimal vascular access choice for patients on hemodialysis
MR Skandari, SM Shechter, N Zalunardo
Manufacturing & Service Operations Management 17 (4), 608-619, 2015
162015
Cost-effectiveness analysis of vascular access referral policies in CKD
SM Shechter, T Chandler, MR Skandari, N Zalunardo
American Journal of Kidney Diseases 70 (3), 368-376, 2017
142017
Longer-term benefits and risks of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a systematic review and meta-analysis
JT Alexander, EM Staab, W Wan, M Franco, A Knitter, MR Skandari, ...
Journal of general internal medicine, 1-10, 2022
112022
The productivity requirements of implementing a medical scribe program
TJ Miksanek, MR Skandari, SA Ham, WW Lee, VG Press, MT Brown, ...
Annals of Internal Medicine 174 (1), 1-7, 2021
102021
Development and validation of a decision analytical model for posttreatment surveillance for patients with oropharyngeal carcinoma
V Nair, S Auger, S Kochanny, FM Howard, D Ginat, O Pasternak-Wise, ...
JAMA Network Open 5 (4), e227240-e227240, 2022
32022
Alternative type 2 diabetes screening tests may reduce the number of US adults with undiagnosed diabetes
RS Dadwani, MR Skandari, MS GoodSmith, LS Phillips, MK Rhee, ...
Diabetic Medicine 37 (11), 1935-1943, 2020
22020
Expected Health Benefits of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Older Adults
RS Dadwani, W Wan, MR Skandari, ES Huang
MDM Policy & Practice 8 (2), 23814683231187566, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20